LBF20207PG63: Difference between revisions
(New page: {{Lipid/Header}} {{Hierarchy|{{PAGENAME}}}} {{Metabolite |LipidBank=XPR1792 |LipidMaps=LMFA03010121 |SysName=(9alpha,11alpha,15R) -Trihydroxy-15-methyl-prosta- (5-cis,13-trans) -dien-1-o...) |
No edit summary |
||
Line 6: | Line 6: | ||
|LipidBank=XPR1792 | |LipidBank=XPR1792 | ||
|LipidMaps=LMFA03010121 | |LipidMaps=LMFA03010121 | ||
|SysName=(9alpha,11alpha,15R) -Trihydroxy-15-methyl-prosta- (5- | |SysName=(9alpha,11alpha,15R) -Trihydroxy-15-methyl-prosta- (cis-5,trans-13) -dien-1-oic acid | ||
|Common Name=&&15R-15-methyl Prostaglandin F_2 alpha&&(9alpha,11alpha,15R) -Trihydroxy-15-methyl-prosta- (5Z,13E) -dien-1-oic acid&& | |Common Name=&&15R-15-methyl Prostaglandin F_2 alpha&&(9alpha,11alpha,15R) -Trihydroxy-15-methyl-prosta- (5Z,13E) -dien-1-oic acid&& | ||
|Source= | |Source= |
Latest revision as of 08:44, 21 October 2010
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR1792 |
LipidMaps | LMFA03010121 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20207PG63 |
15R-15-methyl Prostaglandin F2α | |
---|---|
Structural Information | |
(9α,11α,15R) -Trihydroxy-15-methyl-prosta- (cis-5,trans-13) -dien-1-oic acid | |
| |
Formula | C21H36O5 |
Exact Mass | 368.256274262 |
Average Mass | 368.50754 |
SMILES | C(=C[C@H]([C@H]1CC=CCCCC(O)=O)[C@@H](C[C@@H]1O)O)[C@](C)(O)CCCCC |
Physicochemical Information | |
15(R)-15-methyl PGF2 alpha is converted into the active 15(S)-isomer, which induce luteolysis after injection in rhesus monkeys at a dose of 12 mg/animal. Wilks_JW | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|